Patent ID: 7825160

Claim:
A compound having the general formula (I) wherein A is a ring selected from the group consisting of phenyl; C 3-7 cycloalkyl; and heterocyclyl; X is a linear C 1 -C 4 alkylene group which is optionally substituted with one or more substituents selected from the group consisting of F, CI, Br, I and C 1 -C 4 alkyl, wherein the C 1 -C 4 alkyl group is optionally be substituted with one or more substituents selected from the group consisting of F, CI, Br, and I; R 1 and R 2 are each independently selected from the group consisting of H; alkyl selected from the group consisting of CH 3 , C 2 H 5 , i-C 3 H 7 , n-C 3 H 7 , i-C 4 H 9 , n-C 4 H 9 , sec-C 4 H 9 , and tert-C 4 H 9 ; and alkenyl selected from the group consisting of C 2 H 3 , i-C 3 H 5 , n-C 3 H 5 , n-C 4 H 7 , i-C 4 H 7 , and sec-C 4 H 7 ; or R 1 and R 2 together form a ring, either saturated or unsaturated, with the carbon atom to which they are attached having 3-6 carbon atoms, which may contain in the ring one or more heteroatoms from the group N, S or O, wherein the heteroatoms may be identical or different if more than one heteroatom is present; R 3 , R 4 , R 5 and R 6 are each independently selected from the group consisting of H; F; CI; Br; I; CN; OH; C(O)N(R 7 R 8 ); S(O) 2 R 7 ; SO 2 N(R 7 R 8 ); S(O)N(R 7 R 8 ); N(R 7 )S(O) 2 R 8 ; N(R 8 )S(O)R 8 ; S(O) 2 R 7 ; N(R 7 )S(O) 2 N(R 8 R 8a ); SR 7 ; N(R 7 R 8 ); N(R 7 )C(O)R 8 ; N(R 7 )C(O)N(R 8 R 8a ); N(R 7 )C(O)OR 8 ; OC(O)N(R 7 R 8 ); C(O)R 7 ; substituted or unsubstituted C 1 -C 4 -alkyl; and substituted or unsubstituted C 1 -C 4 -alkoxy; wherein the substituents of the C 1 -C 4 -alkyl and C 1 -C 4 -alkoxy groups are selected from the group consisting of F, CI, Br, I, and CF 3 ; and R 7 , R 8 , and R 8a are independently selected from the group consisting of H; C 1 -C 4 -alkyl; heterocyclyl; and C 3-7 cycloalkyl, wherein the C 1 -C 4 -alkyl, heterocyclyl, and C 3-7 cycloalkyl groups are optionally substituted with one or more substituents selected from the group consisting of F, CI, Br, I and CF 3 ; and/or a pharmaceutically acceptable salt or ester thereof.